Arrow-right Camera
The Spokesman-Review Newspaper

The Spokesman-Review Newspaper The Spokesman-Review

Spokane, Washington  Est. May 19, 1883
Cloudy 29° Cloudy
News >  Business

Recreational cannabis operation planned for Spokane’s Hillyard neighborhood

In a massive growing room, a variety prized for its many flowers on each stock grows at Phat Panda, the largest cannabis growing operation in Spokane, shown in April 2018. (Jesse Tinsley / The Spokesman-Review)
In a massive growing room, a variety prized for its many flowers on each stock grows at Phat Panda, the largest cannabis growing operation in Spokane, shown in April 2018. (Jesse Tinsley / The Spokesman-Review)

Developers of a large recreational cannabis facility are seeking permission to build a 9,500-square-foot plant in Spokane’s Hillyard neighborhood a couple of blocks from a future interchange with the north-south freeway, according to documents filed with the city.

Called the Cashmere Grow Facility, the $400,000 project at 3807 E. Olympic Ave. would house a cannabis-grow facility and include space for harvesting, packaging and offices. A second phase of the project would build a stand-alone “extraction” center, which would produce derivatives of the product.

The property, which is vacant, was purchased in November 2017 for $179,000 by Cashmere Holdings LLC, according to county property records. The land and project owner is listed as Mehran Khosravi.

Cody Dompier, Dompier Architecture in Spokane, is listed as the project’s contact.

The Spokesman-Review Newspaper

Local journalism is essential.

Give directly to The Spokesman-Review's Northwest Passages community forums series -- which helps to offset the costs of several reporter and editor positions at the newspaper -- by using the easy options below. Gifts processed in this system are not tax deductible, but are predominately used to help meet the local financial requirements needed to receive national matching-grant funds.

Active Person

Subscribe to the Coronavirus newsletter

Get the day’s latest Coronavirus news delivered to your inbox by subscribing to our newsletter.